{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:19:33Z","timestamp":1791191973826,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nrendo.2015.224","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T11:25:31Z","timestamp":1453461931000},"page":"168-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":182,"title":["Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis"],"prefix":"10.1038","volume":"12","author":[{"given":"Mirjam","family":"Christ-Crain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Fenske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"key":"BFnrendo2015224_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/clinchem\/45.1.98","volume":"45","author":"M Kluge","year":"1999","unstructured":"Kluge, M., Riedl, S., Erhart-Hofmann, B., Hartmann, J. & Waldhauser, F. Improved extraction procedure and RIA for determination of arginine8-vasopressin in plasma: role of premeasurement sample treatment and reference values in children. Clin. Chem. 45, 98\u2013103 (1999).","journal-title":"Clin. Chem."},{"key":"BFnrendo2015224_CR2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1210\/jc.2010-2499","volume":"96","author":"S Balanescu","year":"2011","unstructured":"Balanescu, S. et al. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar states. J. Clin. Endocrinol. Metab. 96, 1046\u20131052 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","volume":"52","author":"NG Morgenthaler","year":"2006","unstructured":"Morgenthaler, N. G., Struck, J., Alonso, C. & Bergmann, A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem. 52, 112\u2013119 (2006).","journal-title":"Clin. Chem."},{"key":"BFnrendo2015224_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/295299a0","volume":"295","author":"H Land","year":"1982","unstructured":"Land, H., Sch\u00fctz, G., Schmale, H. & Richter, D. Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin\u2013neurophysin II precursor. Nature 295, 299\u2013303 (1982).","journal-title":"Nature"},{"key":"BFnrendo2015224_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1399-3011.1986.tb01827.x","volume":"27","author":"B Levy","year":"1986","unstructured":"Levy, B., Chauvet, M. T., Chauvet, J. & Acher, R. Ontogeny of bovine neurohypophysial hormone precursors. II. Foetal copeptin, the third domain of the vasopressin precursor. Int. J. Pept. Protein Res. 27, 320\u2013324 (1986).","journal-title":"Int. J. Pept. Protein Res."},{"key":"BFnrendo2015224_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/302342a0","volume":"302","author":"H Land","year":"1983","unstructured":"Land, H. et al. Deduced amino acid sequence from the bovine oxytocin\u2013neurophysin I precursor cDNA. Nature 302, 342\u2013344 (1983).","journal-title":"Nature"},{"key":"BFnrendo2015224_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1385\/JMN:18:3:223","volume":"18","author":"R Acher","year":"2002","unstructured":"Acher, R., Chauvet, J. & Rouille, Y. Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport. J. Mol. Neurosci. 18, 223\u2013228 (2002).","journal-title":"J. Mol. Neurosci."},{"key":"BFnrendo2015224_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1023\/A:1022564803093","volume":"18","author":"FM de Bree","year":"1998","unstructured":"de Bree, F. M. & Burbach, J. P. Structure\u2013function relationships of the vasopressin prohormone domains. Cell. Mol. Neurobiol. 18, 173\u2013191 (1998).","journal-title":"Cell. Mol. Neurobiol."},{"key":"BFnrendo2015224_CR9","first-page":"S20","volume":"21","author":"GL Robertson","year":"1987","unstructured":"Robertson, G. L. Physiology of ADH secretion. Kidney Int. Suppl. 21, S20\u2013S26 (1987).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrendo2015224_CR10","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.1523\/JNEUROSCI.0877-06.2006","volume":"26","author":"S Ciura","year":"2006","unstructured":"Ciura, S. & Bourque, C. W. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J. Neurosci. 26, 9069\u20139075 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrendo2015224_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF00218970","volume":"164","author":"F Vandesande","year":"1975","unstructured":"Vandesande, F. & Dierickx, K. Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy system of the rat. Cell Tissue Res. 164, 153\u2013162 (1975).","journal-title":"Cell Tissue Res."},{"key":"BFnrendo2015224_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/299355a0","volume":"299","author":"GE Gillies","year":"1982","unstructured":"Gillies, G. E., Linton, E. A. & Lowry, P. J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299, 355\u2013357 (1982).","journal-title":"Nature"},{"key":"BFnrendo2015224_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/305325a0","volume":"305","author":"C Rivier","year":"1983","unstructured":"Rivier, C. & Vale, W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305, 325\u2013327 (1983).","journal-title":"Nature"},{"key":"BFnrendo2015224_CR14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.neuron.2013.04.025","volume":"78","author":"SJ Son","year":"2013","unstructured":"Son, S. J. et al. Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks. Neuron 78, 1036\u20131049 (2013).","journal-title":"Neuron"},{"key":"BFnrendo2015224_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrn2400","volume":"9","author":"CW Bourque","year":"2008","unstructured":"Bourque, C. W. Central mechanisms of osmosensation and systemic osmoregulation. Nat. Rev. Neurosci. 9, 519\u2013531 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrendo2015224_CR16","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1113\/jphysiol.2010.191940","volume":"588","author":"GM Toney","year":"2010","unstructured":"Toney, G. M. & Stocker, S. D. Hyperosmotic activation of CNS sympathetic drive: implications for cardiovascular disease. J. Physiol. 588, 3375\u20133384 (2010).","journal-title":"J. Physiol."},{"key":"BFnrendo2015224_CR17","first-page":"333","volume":"33","author":"GL Robertson","year":"1976","unstructured":"Robertson, G. L. The regulation of vasopressin function in health and disease. Rec. Prog. Horm. Res. 33, 333\u2013385 (1976).","journal-title":"Rec. Prog. Horm. Res."},{"key":"BFnrendo2015224_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF00580849","volume":"387","author":"FT LaRochelle Jr","year":"1980","unstructured":"LaRochelle, F. T. Jr, North, W. G. & Stern, P. A new extraction of arginine vasopressin from blood: the use of octadecasilyl-silica. Pflugers Arch. 387, 79\u201381 (1980).","journal-title":"Pflugers Arch."},{"key":"BFnrendo2015224_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","volume":"28","author":"NG Morgenthaler","year":"2007","unstructured":"Morgenthaler, N. G. et al. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28, 219\u2013226 (2007).","journal-title":"Shock"},{"key":"BFnrendo2015224_CR20","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1210\/jc.2014-2295","volume":"99","author":"R Roussel","year":"2014","unstructured":"Roussel, R. et al. Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J. Clin. Endocrinol. Metab. 99, 4656\u20134663 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR21","doi-asserted-by":"crossref","first-page":"23282","DOI":"10.1016\/S0021-9258(18)50088-0","volume":"267","author":"MH Nathanson","year":"1992","unstructured":"Nathanson, M. H. et al. Mechanisms of subcellular cytosolic Ca2+ signaling evoked by stimulation of the vasopressin V1a receptor. J. Biol. Chem. 267, 23282\u201323289 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo2015224_CR22","first-page":"1183","volume-title":"Progress in Endocrinology","author":"S Jard","year":"1988","unstructured":"Jard, S., Elands, J., Schmidt, A. & Barberis, C. in Progress in Endocrinology (eds Imura, H. & Shizume, K.) 1183\u20131188 (Elsevier, 1988)."},{"key":"BFnrendo2015224_CR23","first-page":"R671","volume":"253","author":"PH Baylis","year":"1987","unstructured":"Baylis, P. H. Osmoregulation and control of vasopressin secretion in healthy humans. Am. J. Physiol. 253, R671\u2013R678 (1987).","journal-title":"Am. J. Physiol."},{"key":"BFnrendo2015224_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/0006-291X(88)90625-0","volume":"151","author":"G Nagy","year":"1988","unstructured":"Nagy, G., Mulchahey, J. J., Smyth, D. G. & Neill, J. D. The glycopeptide moiety of vasopressin-neurophysin precursor is neurohypophysial prolactin releasing factor. Biochem. Biophys. Res. Commun. 151, 524\u2013529 (1988).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrendo2015224_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1210\/endo-125-1-35","volume":"125","author":"JF Hyde","year":"1989","unstructured":"Hyde, J. F., North, W. G. & Ben-Jonathan, N. The vasopressin-associated glycopeptide is not a prolactin-releasing factor: studies with lactating Brattleboro rats. Endocrinology 125, 35\u201340 (1989).","journal-title":"Endocrinology"},{"key":"BFnrendo2015224_CR26","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.1021\/bi0400094","volume":"43","author":"C Barat","year":"2004","unstructured":"Barat, C., Simpson, L. & Breslow, E. Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus. Biochemistry 43, 8191\u20138203 (2004).","journal-title":"Biochemistry"},{"key":"BFnrendo2015224_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.biochem.69.1.69","volume":"69","author":"AJ Parodi","year":"2000","unstructured":"Parodi, A. J. Protein glucosylation and its role in protein folding. Annu. Rev. Biochem. 69, 69\u201393 (2000).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnrendo2015224_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0968-0004(02)00004-X","volume":"28","author":"JD Schrag","year":"2003","unstructured":"Schrag, J. D., Procopio, D. O., Cygler, M., Thomas, D. Y. & Bergeron, J. J. Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem. Sci. 28, 49\u201357 (2003).","journal-title":"Trends Biochem. Sci."},{"key":"BFnrendo2015224_CR29","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2215\/CJN.11311111","volume":"7","author":"D Zittema","year":"2012","unstructured":"Zittema, D. et al. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. Clin. J. Am. Soc. Nephrol. 7, 906\u2013913 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrendo2015224_CR30","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2215\/CJN.08690813","volume":"9","author":"D Zittema","year":"2014","unstructured":"Zittema, D. et al. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. Clin. J. Am. Soc. Nephrol. 9, 1553\u20131562 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrendo2015224_CR31","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1210\/jc.2014-4507","volume":"100","author":"K Timper","year":"2015","unstructured":"Timper, K. et al. Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study. J. Clin. Endocrinol. Metab. 100, 2268\u20132274 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR32","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1210\/jc.2010-2345","volume":"96","author":"W Fenske","year":"2011","unstructured":"Fenske, W. et al. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome \u2014 revisiting the direct and indirect water deprivation tests. J. Clin. Endocrinol. Metab. 96, 1506\u20131515 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR33","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1210\/jcem-37-4-616","volume":"37","author":"MK Husain","year":"1973","unstructured":"Husain, M. K., Fernando, N., Shapiro, M., Kagan, A. & Glick, S. M. Radioimmunoassay of arginine vasopressin in human plasma. J. Clin. Endocrinol. Metab. 37, 616\u2013625 (1973).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR34","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1172\/JCI107423","volume":"52","author":"GL Robertson","year":"1973","unstructured":"Robertson, G. L., Mahr, E. A., Athar, S. & Sinha, T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J. Clin. Invest. 52, 2340\u20132352 (1973).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2015224_CR35","first-page":"229","volume":"30","author":"AL Gerbes","year":"1992","unstructured":"Gerbes, A. L., Witthaut, R., Samson, W. K., Schnizer, W. & Vollmar, A. M. A highly sensitive and rapid radioimmunoassay for the determination of arginine8-vasopressin. Eur. J. Clin. Chem. Clin. Biochem. 30, 229\u2013233 (1992).","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"BFnrendo2015224_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0378-4347(91)80380-U","volume":"565","author":"BJ Van de Heijning","year":"1991","unstructured":"Van de Heijning, B. J., Koekkoek-van den Herik, I., Iv\u00e1nyi, T. & Van Wimersma Greidanus, T. B. Solid-phase extraction of plasma vasopressin: evaluation, validation and application. J. Chromatogr. 565, 159\u2013171 (1991).","journal-title":"J. Chromatogr."},{"key":"BFnrendo2015224_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/09537109777492","volume":"8","author":"T Wun","year":"1997","unstructured":"Wun, T. Vasopressin and platelets: a concise review. Platelets 8, 15\u201322 (1997).","journal-title":"Platelets"},{"key":"BFnrendo2015224_CR38","doi-asserted-by":"publisher","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","volume":"5","author":"JJ Preibisz","year":"1983","unstructured":"Preibisz, J. J., Sealey, J. E., Laragh, J. H., Cody, R. J. & Weksler, B. B. Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension 5, I129\u2013I138 (1983).","journal-title":"Hypertension"},{"key":"BFnrendo2015224_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0009-9120(02)00440-X","volume":"36","author":"M Jane Ellis","year":"2003","unstructured":"Jane Ellis, M., Livesey, J. H. & Evans, M. J. Hormone stability in human whole blood. Clin. Biochem. 36, 109\u2013112 (2003).","journal-title":"Clin. Biochem."},{"key":"BFnrendo2015224_CR40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/JCI108377","volume":"57","author":"G Baumann","year":"1976","unstructured":"Baumann, G. & Dingman, J. F. Distribution, blood transport, and degradation of antidiuretic hormone in man. J. Clin. Invest. 57, 1109\u20131116 (1976).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2015224_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/CS20080140","volume":"116","author":"SS Bhandari","year":"2009","unstructured":"Bhandari, S. S. et al. Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin. Sci. (Lond.) 116, 257\u2013263 (2009).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrendo2015224_CR42","unstructured":"US National Library of Science. ClinicalTrials.gov [online] , (2015)."},{"key":"BFnrendo2015224_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3109\/1354750X.2014.940504","volume":"19","author":"C Walti","year":"2014","unstructured":"Walti, C., Siegenthaler, J. & Christ-Crain, M. Copeptin levels are independent of ingested nutrient type after standardised meal administration \u2014 the CoMEAL study. Biomarkers 19, 557\u2013562 (2014).","journal-title":"Biomarkers"},{"key":"BFnrendo2015224_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2362.2006.01591.x","volume":"36","author":"JJ Puder","year":"2006","unstructured":"Puder, J. J. et al. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur. J. Clin. Invest. 36, 58\u201364 (2006).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnrendo2015224_CR45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.21783","volume":"66","author":"M Katan","year":"2009","unstructured":"Katan, M. et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann. Neurol. 66, 799\u2013808 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnrendo2015224_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","volume":"54","author":"T Reichlin","year":"2009","unstructured":"Reichlin, T. et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J. Am. Coll. Cardiol. 54, 60\u201368 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrendo2015224_CR47","first-page":"w13101","volume":"140","author":"M Katan","year":"2010","unstructured":"Katan, M. & Christ-Crain, M. The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Med. Wkly 140, w13101 (2010).","journal-title":"Swiss Med. Wkly"},{"key":"BFnrendo2015224_CR48","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1530\/EJE-14-0405","volume":"171","author":"J Siegenthaler","year":"2014","unstructured":"Siegenthaler, J., Walti, C., Urwyler, S. A., Schuetz, P. & Christ-Crain, M. Copeptin concentrations during psychological stress: the PsyCo study. Eur. J. Endocrinol. 171, 737\u2013742 (2014).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2015224_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/10253890.2014.993966","volume":"18","author":"SA Urwyler","year":"2015","unstructured":"Urwyler, S. A., Schuetz, P., Sailer, C. & Christ-Crain, M. Copeptin as a stress marker prior and after a written examination \u2014 the CoEXAM study. Stress 18, 134\u2013137 (2015).","journal-title":"Stress"},{"key":"BFnrendo2015224_CR50","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1210\/jc.2012-1981","volume":"97","author":"W Fenske","year":"2012","unstructured":"Fenske, W. & Allolio, B. Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J. Clin. Endocrinol. Metab. 97, 3426\u20133437 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR51","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/jcem-7-11-753","volume":"7","author":"AC Carter","year":"1947","unstructured":"Carter, A. C. & Robbins, J. The use of hypertonic saline infusions in the differential diagnosis of diabetes insipidus and psychogenic polydipsia. J. Clin. Endocrinol. Metab. 7, 753\u2013766 (1947).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR52","first-page":"235","volume":"28","author":"ED Barlow","year":"1959","unstructured":"Barlow, E. D. & De Wardener, H. E. Compulsive water drinking. Q. J. Med. 28, 235\u2013258 (1959).","journal-title":"Q. J. Med."},{"key":"BFnrendo2015224_CR53","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jama.1963.03060090031011","volume":"185","author":"AM Dashe","year":"1963","unstructured":"Dashe, A. M., Cramm, R. E., Crist, C. A., Habener, J. F. & Solomon, D. H. A water deprivation test for the differential diagnosis of polyuria. JAMA 185, 699\u2013703 (1963).","journal-title":"JAMA"},{"key":"BFnrendo2015224_CR54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7326\/0003-4819-73-5-721","volume":"73","author":"M Miller","year":"1970","unstructured":"Miller, M., Dalakos, T., Moses, A. M., Fellerman, H. & Streeten, D. H. Recognition of partial defects in antidiuretic hormone secretion. Ann. Intern. Med. 73, 721\u2013729 (1970).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo2015224_CR55","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-54-4-710","volume":"54","author":"F Dies","year":"1961","unstructured":"Dies, F., Rangel, S. & Rivera, A. Differential diagnosis between diabetes insipidus and compulsive polydipsia. Ann. Intern. Med. 54, 710\u2013725 (1961).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo2015224_CR56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0889-8529(18)30031-8","volume":"24","author":"GL Robertson","year":"1995","unstructured":"Robertson, G. L. Diabetes insipidus. Endocrinol. Metab. Clin. North Am. 24, 549\u2013572 (1995).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"BFnrendo2015224_CR57","first-page":"176","volume-title":"Diabetes Insipidus in Man","author":"GL Robertson","year":"1985","unstructured":"Robertson, G. L. in Diabetes Insipidus in Man. (eds Czernichow, P. & Robinson, A. G.) 176\u2013189 (Karger, 1985)."},{"key":"BFnrendo2015224_CR58","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1530\/acta.0.1040410","volume":"104","author":"JJ Milles","year":"1983","unstructured":"Milles, J. J., Spruce, B. & Baylis, P. H. A comparison of diagnostic methods to differentiate diabetes insipidus from primary polyuria: a review of 21 patients. Acta Endocrinol. (Copenh.) 104, 410\u2013416 (1983).","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BFnrendo2015224_CR59","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1521-690X(03)00049-6","volume":"17","author":"JG Verbalis","year":"2003","unstructured":"Verbalis, J. G. Disorders of body water homeostasis. Best Pract. Res. Clin. Endocrinol. Metab. 17, 471\u2013503 (2003).","journal-title":"Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR60","doi-asserted-by":"publisher","first-page":"F965","DOI":"10.1152\/ajprenal.00085.2003","volume":"285","author":"MA Cadnapaphornchai","year":"2003","unstructured":"Cadnapaphornchai, M. A. et al. Effect of primary polydipsia on aquaporin and sodium transporter abundance. Am. J. Physiol. Renal Physiol. 285, F965\u2013F971 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrendo2015224_CR61","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1172\/JCI103541","volume":"36","author":"RW Berliner","year":"1957","unstructured":"Berliner, R. W. & Davidson, D. G. Production of hypertonic urine in the absence of pituitary antidiuretic hormone. J. Clin. Invest. 36, 1416\u20131427 (1957).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2015224_CR62","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1172\/JCI105746","volume":"47","author":"AR Harrington","year":"1968","unstructured":"Harrington, A. R. & Valtin, H. Impaired urinary concentration after vasopressin and its gradual correction in hypothalamic diabetes insipidus. J. Clin. Invest. 47, 502\u2013510 (1968).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2015224_CR63","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/BF01721052","volume":"59","author":"LH Block","year":"1981","unstructured":"Block, L. H., Furrer, J., Locher, R. A., Siegenthaler, W. & Vetter, W. Changes in tissue sensitivity to vasopressin in hereditary hypothalamic diabetes insipidus. Klin. Wochenschr. 59, 831\u2013836 (1981).","journal-title":"Klin. Wochenschr."},{"key":"BFnrendo2015224_CR64","first-page":"F100","volume":"237","author":"M Gellai","year":"1979","unstructured":"Gellai, M., Edwards, B. R. & Valtin, H. Urinary concentrating ability during dehydration in the absence of vasopressin. Am. J. Physiol. 237, F100\u2013F104 (1979).","journal-title":"Am. J. Physiol."},{"key":"BFnrendo2015224_CR65","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/014107688007300408","volume":"73","author":"PH Baylis","year":"1980","unstructured":"Baylis, P. H. & Robertson, G. L. Plasma vasopressin response to hypertonic saline infusion to assess posterior pituitary function. J. R. Soc. Med. 73, 255\u2013260 (1980).","journal-title":"J. R. Soc. Med."},{"key":"BFnrendo2015224_CR66","first-page":"345","volume":"50","author":"PH Baylis","year":"1981","unstructured":"Baylis, P. H., Gaskill, M. B. & Robertson, G. L. Vasopressin secretion in primary polydipsia and cranial diabetes insipidus. Q. J. Med. 50, 345\u2013358 (1981).","journal-title":"Q. J. Med."},{"key":"BFnrendo2015224_CR67","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJM198112243052601","volume":"305","author":"RL Zerbe","year":"1981","unstructured":"Zerbe, R. L. & Robertson, G. L. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N. Engl. J. Med. 305, 1539\u20131546 (1981).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2015224_CR68","first-page":"108","volume":"32","author":"PH Baylis","year":"1998","unstructured":"Baylis, P. H. Diabetes insipidus. J. R. Coll. Physicians Lond. 32, 108\u2013111 (1998).","journal-title":"J. R. Coll. Physicians Lond."},{"key":"BFnrendo2015224_CR69","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1172\/JCI105040","volume":"43","author":"JW Czaczkes","year":"1964","unstructured":"Czaczkes, J. W. & Kleeman, C. R. The effect of various states of hydration and the plasma concentration on the turnover of antidiuretic hormone in mammals. J. Clin. Invest. 43, 1649\u20131658 (1964).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2015224_CR70","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1210\/jc.2006-2046","volume":"92","author":"M Katan","year":"2007","unstructured":"Katan, M. et al. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. J. Clin. Endocrinol. Metab. 92, 2640\u20132643 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR71","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1210\/jc.2014-4527","volume":"100","author":"B Winzeler","year":"2015","unstructured":"Winzeler, B. et al. Postoperative copeptin concentration predicts diabetes insipidus after pituitary surgery. J. Clin. Endocrinol. Metab. 100, 2275\u20132282 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR72","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1210\/jc.2014-4507","volume":"100","author":"K Timper","year":"2015","unstructured":"Timper, K. et al. Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study. J. Clin. Endocrinol. Metab. 100, 2268\u20132274 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR73","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1210\/jc.2002-020090","volume":"87","author":"D Smith","year":"2002","unstructured":"Smith, D. et al. Baroregulation of vasopressin release in adipsic diabetes insipidus. J. Clin. Endocrinol. Metab. 87, 4564\u20134568 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR74","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2013)."},{"key":"BFnrendo2015224_CR75","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(97)12169-9","volume":"352","author":"S Kumar","year":"1998","unstructured":"Kumar, S. & Berl, T. Sodium. Lancet 352, 220\u2013228 (1998).","journal-title":"Lancet"},{"key":"BFnrendo2015224_CR76","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","volume":"119","author":"A Upadhyay","year":"2006","unstructured":"Upadhyay, A., Jaber, B. L. & Madias, N. E. Incidence and prevalence of hyponatremia. Am. J. Med. 119, S30\u2013S35 (2006).","journal-title":"Am. J. Med."},{"key":"BFnrendo2015224_CR77","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1210\/jc.2008-0330","volume":"93","author":"W Fenske","year":"2008","unstructured":"Fenske, W. et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J. Clin. Endocrinol. Metab. 93, 2991\u20132997 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1210\/jc.2008-1426","volume":"94","author":"W Fenske","year":"2009","unstructured":"Fenske, W. et al. Copeptin in the differential diagnosis of hyponatremia. J. Clin. Endocrinol. Metab. 94, 123\u2013129 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2015224_CR79","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0002-9343(93)90179-S","volume":"94","author":"WW Tang","year":"1993","unstructured":"Tang, W. W., Kaptein, E. M., Feinstein, E. I. & Massry, S. G. Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am. J. Med. 94, 169\u2013174 (1993).","journal-title":"Am. J. Med."},{"key":"BFnrendo2015224_CR80","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","volume":"120","author":"JG Verbalis","year":"2007","unstructured":"Verbalis, J. G., Goldsmith, S. R., Greenberg, A., Schrier, R. W. & Sterns, R. H. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am. J. Med. 120, S1\u2013S21 (2007).","journal-title":"Am. J. Med."},{"key":"BFnrendo2015224_CR81","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0002-9343(87)90649-8","volume":"83","author":"HM Chung","year":"1987","unstructured":"Chung, H. M., Kluge, R., Schrier, R. W. & Anderson, R. J. Clinical assessment of extracellular fluid volume in hyponatremia. Am. J. Med. 83, 905\u2013908 (1987).","journal-title":"Am. J. Med."},{"key":"BFnrendo2015224_CR82","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","volume":"126","author":"JG Verbalis","year":"2013","unstructured":"Verbalis, J. G. et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am. J. Med. 126, S1\u2013S42 (2013).","journal-title":"Am. J. Med."},{"key":"BFnrendo2015224_CR83","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","volume":"355","author":"RW Schrier","year":"2006","unstructured":"Schrier, R. W. et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355, 2099\u20132112 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo2015224_CR84","doi-asserted-by":"publisher","first-page":"71.e1","DOI":"10.1016\/j.amjmed.2005.09.026","volume":"119","author":"B Renneboog","year":"2006","unstructured":"Renneboog, B., Musch, W., Vandemergel, X., Manto, M. U. & Decaux, G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am. J. Med. 119, 71.e1\u201371.e8 (2006).","journal-title":"Am. J. Med."},{"key":"BFnrendo2015224_CR85","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1359\/jbmr.090827","volume":"25","author":"JG Verbalis","year":"2010","unstructured":"Verbalis, J. G. et al. Hyponatremia-induced osteoporosis. J. Bone Miner. Res. 25, 554\u2013563 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo2015224_CR86","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.amjmed.2010.01.013","volume":"123","author":"W Fenske","year":"2010","unstructured":"Fenske, W., Maier, S. K., Blechschmidt, A., Allolio, B. & St\u00f6rk, S. Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am. J. Med. 123, 652\u2013657 (2010).","journal-title":"Am. J. Med."},{"key":"BFnrendo2015224_CR87","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.clinbiochem.2015.03.013","volume":"48","author":"G Boursier","year":"2015","unstructured":"Boursier, G. et al. CT-pro-AVP as a tool for assessment of intravascular volume depletion in severe hyponatremia. Clin. Biochem. 48, 640\u2013645 (2015).","journal-title":"Clin. Biochem."},{"key":"BFnrendo2015224_CR88","first-page":"173","volume":"35","author":"N Nigro","year":"2014","unstructured":"Nigro, N. et al. Copeptin for the differential diagnosis and therapy management of hyponatremia in hospitalized patients \u2014 'the Co-MED-Study'. Endocr. Abstr. 35, 173 (2014).","journal-title":"Endocr. Abstr."},{"key":"BFnrendo2015224_CR89","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev.me.31.020180.001531","volume":"31","author":"R Zerbe","year":"1980","unstructured":"Zerbe, R., Stropes, L. & Robertson, G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu. Rev. Med. 31, 315\u2013327 (1980).","journal-title":"Annu. Rev. Med."},{"key":"BFnrendo2015224_CR90","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1681\/ASN.2013080895","volume":"25","author":"WK Fenske","year":"2014","unstructured":"Fenske, W. K. et al. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis. J. Am. Soc. Nephrol. 25, 2376\u20132383 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo2015224_CR91","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.2215\/CJN.00160106","volume":"1","author":"A Soupart","year":"2006","unstructured":"Soupart, A. et al. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin. J. Am. Soc. Nephrol. 1, 1154\u20131160 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrendo2015224_CR92","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrendo.2010.229","volume":"7","author":"GL Robertson","year":"2011","unstructured":"Robertson, G. L. Vaptans for the treatment of hyponatremia. Nat. Rev. Endocrinol. 7, 151\u2013161 (2011).","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.224","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:46:25Z","timestamp":1684467985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2015.224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnrendo2015224"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2015.224","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]},"assertion":[{"value":"22 January 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M. C.-C. and W. F. have received speaking honoraria from Thermo Fisher AG, the manufacturer of the Copeptin Assay.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}